Chordia---bioventure advancing the development of potential blockbuster anticancer drugs at block inc.

Fisco Japan · 11:37

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

Ｃｈｏｒｄｉａ---ブロックバスター候補になりうる抗がん薬の開発を進めるバイオベンチャー

Chordia---bioventure advancing the development of potential blockbuster anticancer drugs at block inc.

Risk Disclaimer

Statement